Michael Stewart Lee Igm Biosciences, Inc. (IGMS) insider trading activity

Michael Stewart Lee is Director of IGM Biosciences, Inc.. Currently has a direct ownership of 11,884 shares of IGMS, which is worth approximately $15,686. The most recent transaction as insider was on Mar 31, 2025, when has been sold 828 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.9K

7.49% 3M change

103.01% 12M change

Total Value Held $15,686

Michael Stewart Lee Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2025	BUY Grant, award, or other acquisition	-	828 Added 6.51%	11,884 Common Stock
Dec 31 2024	BUY Grant, award, or other acquisition	-	1,734 Added 13.56%	11,056 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	-	1,734 Added 15.68%	9,322 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	-	1,734 Added 18.6%	7,588 Common Stock
Mar 29 2024	BUY Grant, award, or other acquisition	-	1,734 Added 22.85%	5,854 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	-	492 Added 10.67%	4,120 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	-	492 Added 11.94%	3,628 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	492 Added 13.56%	3,136 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	492 Added 15.69%	2,644 Common Stock
Dec 30 2022	BUY Grant, award, or other acquisition	-	230 Added 9.66%	2,152 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	230 Added 10.69%	1,922 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	230 Added 11.97%	1,692 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	230 Added 13.59%	1,462 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	-	130 Added 9.54%	1,232 Common Stock
Sep 30 2021	BUY Grant, award, or other acquisition	-	130 Added 10.55%	1,102 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	130 Added 11.8%	972 Common Stock
Mar 31 2021	BUY Grant, award, or other acquisition	-	130 Added 13.37%	842 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	-	178 Added 20.0%	712 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	-	178 Added 25.0%	534 Common Stock

Also insider at

STTK

Shattuck Labs, Inc. Healthcare

Director

FATE

FATE THERAPEUTICS INC Healthcare

Director

MSL